Jinling Pharmaceutical Co Ltd
000919
Company Profile
Business description
Jinling Pharmaceutical Co Ltd is a China-based pharmaceutical company. The company is engaged in production and sales of Chinese and Western medicine raw materials and preparations, biochemical products, pharmaceutical packaging products, medical devices, and natural beverages.
Contact
No. 238 Zhongyang Road
Jinling Pharmaceutical Building
NanjingJiangsu210009
CHNT: +86 2583118511
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
5,789
Stocks News & Analysis
stocks
Overvalued ASX share as market underestimates downside risks
Growth outlook solid, but upside more than priced in.
stocks
New production imminent for undervalued ASX gas play
LNG project receives first commissioning gas.
stocks
Going into earnings, is Tesla stock a buy, a sell, or fairly valued?
Awaiting more info on robotaxis and lower cost models, here’s what we think of Tesla stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,324.60 | 40.80 | 0.44% |
| CAC 40 | 8,161.78 | 26.81 | -0.33% |
| DAX 40 | 24,113.83 | 282.84 | 1.19% |
| Dow JONES (US) | 46,190.61 | 238.37 | 0.52% |
| FTSE 100 | 9,391.53 | 36.96 | 0.40% |
| HKSE | 25,858.83 | 611.73 | 2.42% |
| NASDAQ | 22,679.97 | 117.44 | 0.52% |
| Nikkei 225 | 49,185.50 | 1,603.35 | 3.37% |
| NZX 50 Index | 13,344.96 | 55.75 | 0.42% |
| S&P 500 | 6,664.01 | 34.94 | 0.53% |
| S&P/ASX 200 | 9,031.90 | 43.70 | 0.49% |
| SSE Composite Index | 3,863.89 | 24.14 | 0.63% |